“…In our opinion, there is a clear trend towards the use of the TLC bioautography technique as a method for screening active compounds against microorganisms rather than a method for the detection of enzyme activities or inhibitors. The use of TLC (bio)autography was reported for the screening of inhibitors of acetylcholinesterase [12][13][14][15][16][17][18][19][20][21][22][23][24][25][26] , butyrylcholinesterase 12,16,22,23,27 , dipeptidyl peptidase IV 28 , glucose-6-phosphate dehydrogenase 29 , a-and b-glucosidases [30][31][32][33][34] , lipase [35][36][37] , monoamine oxidases A and B 38,39 , DNA topoisomerase I 40 , tyrosinase [41][42][43] and xanthine oxidase 44 . To date, the use of the TLC-based autographic method for the detection of PGI inhibition has only been developed for a biocatalyst isolated from the reference E. coli strain ATCC (American Type Culture Collection) 25922 45 .…”